Northeastern University, Massachusetts
John W. Devlin, PharmD, BCCCP, MCCM, is a Professor of Pharmacy at Northeastern University and a Critical Care Pharmacist and Scientific Staff in the Division of Pulmonary and Critical Care at Brigham and Women's Hospital. His federally-funded research program, focused on the detection, prevention and treatment of delirium and disrupted sleep in the ICU has generated more than $5 million in funding and more than 250 publications. He is a member of the Editorial Board of Critical Care Medicine. He also chaired SCCM’s 2018 Pain, Agitation, Delirium, Immobility and Disrupted Sleep Clinical Practice Guidelines.
Pro: Costs and Resources Must Impact Clinical Decision-Making in the ICU
Sunday, March 22, 2026
10:55 AM - 11:15 AM Central Time
Disclosure(s): Certibell Inc: Consultant (Ongoing); National Institute of Aging: Clinical Trial Investigator (Ongoing); Noven Pharmaceuticals: Consultant (Ongoing)
Celebrating a Dozen Years of ICU Liberation: Assessing the Impact of the PADIS Guidelines
Sunday, March 22, 2026
4:35 PM - 4:50 PM Central Time
Disclosure(s): Certibell Inc: Consultant (Ongoing); National Institute of Aging: Clinical Trial Investigator (Ongoing); Noven Pharmaceuticals: Consultant (Ongoing)
Age Effect on Sedation With Dexmedetomidine vs Propofol in Mechanically Ventilated Septic Patients
Monday, March 23, 2026
10:15 AM - 11:15 AM Central Time
Disclosure information not submitted.
Impact of ARDS on Post-ICU Psychoactive Medication Prescribing Without a Justifying Diagnosis
Tuesday, March 24, 2026
10:00 AM - 11:00 AM Central Time
Disclosure information not submitted.